Browse articles from EyeWorld.org related to refractive surgery. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ First patient treated with novel crosslinking approach for refractive error ➤ Multisociety working group established to set guidelines for modern IOL classification ➤ FDA reduces clinical trial requirement for new drugs to one pivotal trial ➤ ASCRS news and events
➤ Study: ‘revolutionary,’ ‘world-first’ treatment for vision-threatening condition restores sight ➤ IDE granted to tissue-based presbyopia solution ➤ Fast Track designation granted for geographic atrophy treatment ➤ Phase 1 results for Stargardt gene therapy ➤ Topline Phase 1b results from study comparing a next-gen treatment to faricimab ➤ Enrolled patients complete dosing in part of trial evaluating X-linked retinoschisis therapy ➤ Company news ➤ ASCRS news and events
The ocular surface impacts many ophthalmic subspecialties beyond cornea. Whether it’s within refractive surgery, cataract surgery, glaucoma therapy, or retina procedures, the ocular surface can affect outcomes for patients being treated by these subspecialists. Several anterior segment ophthalmologists spoke about the ocular surface and how it relates to their subspecialty.
➤ Insulin-based treatment for neurotropic keratitis advances ➤ Study evaluating implantable telescope in patients with late-stage AMD begins ➤ Registrational trial to begin for investigational neuroprotective therapy ➤ Enrollment complete in pivotal trials for wet AMD treatment ➤ ASCRS news and events
While laser vision correction and IOL exchange remain the preferred methods for correcting residual refractive error, two ophthalmologists said there is still a place for piggyback IOLs. They spoke about when they would consider a piggyback IOL, their preferred lenses, and their thoughts on newer generation IOL options.
➤ Phase 1/2 trial update for Leber congenital amaurosis gene therapy in pediatric patients ➤ Primary endpoint not met in Phase 2b trial investigating persistent corneal epithelial defect treatment ➤ Study: treatment for uveal melanoma could improve survival rate ➤ Company news ➤ ASCRS news and events
Two physicians discussed finding the right refraction in patients with keratoconus, what to take into account, and considerations if patients are seeking surgery.
“Even with the wealth of new technologies available … refractive surprises, longer and shorter eyes, and unique medical histories persist. During these times we are called to flex our expertise and go beyond the routine to meet the needs of these patients,” said Karolinne Rocha, MD, introducing the articles in the Refractive section.
➤ Phase 2 trial is the ‘first and only’ to show vision improvement for Stargardt disease ➤ IND accepted for retinal disease gene therapy and Phase 1/2 trial to begin ➤ First patients dosed in trial evaluating retinitis pigmentosa treatment ➤ LASIK alternative being researched ➤ Partnership news ➤ ASCRS news and events
➤ FDA approves first-in-class DED drop ➤ FDA accepts NDA for topical presbyopia therapy ➤ TFOS DEWS III ➤ Topline results in Phase 3 study evaluating night driving impairment after keratorefractive surgery ➤ IND application submitted for pediatric myopia treatment ➤ Study sheds light on clinical inherited retinal diseases without genetic mutations ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.